Alli to launch new chewable tablets for overweight adults
alli, a trade mark of GlaxoSmithKline, is planning to launch new chewable tablets for overweight adults, which are to be on sale in pharmacies in the UK in April 2011.
Federal health officials are warning consumers that the weight loss pill alli may cause severe liver damage in rare cases.